Allison Hagerman, VP, Product Development at ONCOLYTICS BIOTECH INC (ONCY), bought 10,000 shares at $0.83 ($8K) on 2026-02-12, disclosed to the SEC on 2026-02-13.
Open-market purchase of $8k ONCY by VP, Product Development. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.